Novavax is looking ahead to 2024, with the TGA currently assessing its submission for its updated monovalent XBB.1.5 COVID-19 vaccine and a plan to progress the development of its combination COVID-influenza vaccine. …
Novavax looking to 2024 with monovalent COVID vaccine and potential combination
December 20, 2023 Latest NewsBioPharmaNews of the DayBioPharmaDispatch Executive
Latest Video
New Stories
-
Medicines Australia seeks answers on AI in HTA process
September 23, 2026 - - Latest News -
The prevention gap and inside Sally Panton's bet on cellular health
September 23, 2026 - - Latest News -
Pfizer 'deeply disappointed' in response to PBAC refusing to move on price
September 23, 2026 - - Latest News -
Lilly goes direct with a patient platform for its non-PBS medicines
September 23, 2026 - - Latest News -
A 'multistakeholder' reference group to shadow agreement negotiations
September 23, 2026 - -
If there is a productivity gain in the process, then it should be passed on
September 22, 2026 - - Latest News -
Given the official use of AI, a cease and desist would not be unreasonable
September 22, 2026 - - Latest News